Organisation paid for research Program year 2025 Source: CMS Open Payments

Nephrotex Research Group LLC

Neither a doctor nor a teaching hospital

Research payments

$163,400

72 payments

Through program year 2025, Nephrotex Research Group LLC is reported as receiving $163,400 in research payments, across 72 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$23,778	6
2024	Research	$53,293	16
2023	Research	$43,957	14
2022	Research	$6,500	1
2021	Research	$14,623	10
2020	Research	$16,067	10
2019	Research	$5,182	15

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $60,654 9 payments
Retrophin, Inc. $35,941 30 payments
Hoffmann-La Roche Limited $34,656 6 payments
EMD Serono, Inc. $12,694 22 payments
Alexion Pharmaceuticals, Inc. $10,900 2 payments
Mallinckrodt Hospital Products Inc. $8,555 3 payments

Studies the money was for Research payments · program years 2019–2025

Gazyva for the Treatment of MN $60,654 9 payments
Double blind study to determine efficacy of ASO Factor B in IgAN $34,656 6 payments
021Fsgs16010 $23,389 18 payments
A Phase 2, Double Blind, Randomized, Placebo Controlled Study of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) $10,900 2 payments
Clinical Trial Payments for Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) (DUPLEX) $9,670 10 payments
Two Part Prospective Study of H.P. Acthar Gel in the Treatment of Proteinuria Due to Idiopathis Focal Segmental Glomerulosclerosis (FSGS) $8,555 3 payments
A Phase II, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Atacicept in IgA Nephropathy $7,512 7 payments
Ms 700461-0035 $4,546 6 payments
021Igan17001 $2,882 2 payments
Ms700461-0035 $636 9 payments

What the money was spent on Research payments · program years 2019–2025

Other $26,838 22 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.